Clinical Trial

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

Study acronym: DEVALPO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2025 (before its estimated April 18, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this pre-market clinical investigation is to assess the safety and the performance of decongestant seawater spray pocket valve enriched with essential oils by Gilbert Laboratories. The study will evaluate the results of acute rhinitis associated with nasal obstruction using the decongestant seawaterspray pocket valve enriched with essential oils over a 8 day period.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-08-08; most recent amendment 2025-09-19.
Status change: Not Yet Recruiting → Recruiting 2023-06-23
Trial Details
NCT Number NCT05494346
Lead Sponsor Laboratoires Gilbert
Collaborators: EVAMED
Conditions Acute Rhinitis, Nasal Obstruction, Rhinosinusitis, Rhinopharyngitis, Allergic Rhinitis
Enrollment 101 participants
Start Date 2023-06-23
Primary Completion 2026-04-18 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-25